Antiviral activity of TMC435 monotherapy in patients infected with HCV genotypes 2–6: TMC435-C202, a phase IIa, open-label study
Christophe Moreno, Thomas Berg, Tawesak Tanwandee, Satawat Thongsawat, Hans Van Vlierberghe, Stefan Zeuzem, Oliver Lenz, Monika Peeters, Vanitha Sekar, Goedele De SmedtVolume:
56
Year:
2012
Language:
english
DOI:
10.1016/j.jhep.2011.12.033
File:
PDF, 690 KB
english, 2012